Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Targeted Stellate Ganglion Morphine Infiltration on Reperfusion Injury in STEMI Patients After Primary PCI: A Randomized Controlled Trial

NCT06947135 is registered in ClinicalTrials.gov with The Second Hospital of Anhui Medical University as lead sponsor.

NCT NCT06947135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06947135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Targeted Stellate Ganglion Morphine Infiltration on Reperfusion Injury in STEMI Patients After Primary PCI: A Randomized Controlled Trial
Lead sponsor
The Second Hospital of Anhui Medical University
Phase
Not applicable
Overall status
Recruiting
Start date
May 29, 2025
Completion date
June 30, 2026
Enrollment
166 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction